Article Details

Wave Life Sciences Announces Proof-of-Concept Preclinical Data for ADAR Editing Program in ...

Retrieved on: 2021-06-02 20:48:45

Tags for this article:

Click the tags to see associated articles and topics

Wave Life Sciences Announces Proof-of-Concept Preclinical Data for ADAR Editing Program in .... View article details on hiswai: https://www.globenewswire.com/news-release/2021/06/02/2240827/0/en/Wave-Life-Sciences-Announces-Proof-of-Concept-Preclinical-Data-for-ADAR-Editing-Program-in-Alpha-1-Antitrypsin-Deficiency.html

Excerpt

Wave's program in alpha-1 antitrypsin deficiency aims to correct the single base mutation in mRNA derived from the SERPINA1 Z allele, thereby ...

Article found on: www.globenewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up